bio pharmaceutical

News: Chimerix Equity Offering $CMRX

Chimerix Inc., has priced its public offering of 3.775 Million Common shares at $39.75 per share. Gross Proceeds would be of $150,056,250. Bid will be closed by June 16, and the Net proceeds will fund R&D, working capital and general corporate purposes. View the full release here.

Nymox Revenues down $NYMX $XHS

Nymox Pharmaceutical Corporation is a bio pharmaceutical company, has announced its Annual Financial result s for FY-2014. As per the report the firm Revenues down by 57%, EPS was -#0.13 and Quick Assets were $0.6 Million 100% up. View the full earnings release here.